Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Telavancin (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- 25 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Jul 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 30 Jun 2015 Planned initiation date changed from 1 May 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.